Innovating medication reviews through a technology-enabled process

Thiruchelvam, Kaeshaelya; Byles, Julie; Hasan, Syed Shahzad; Kairuz, Therése

doi:10.1016/j.sapharm.2021.07.019

Cited by 1 publication

(3 citation statements)

References 27 publications

(40 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…MedReview anonymizes patient information and does not disclose information to third parties, except a summary of the review emailed to the user. The initiative and intention to use a tool such as MedReview could be due to various reasons [ 3 ]. First, MedReview is capable of ensuring a systematic and structured review due to the guided framework embedded within it, and is stepwise in nature.…”

Section: Discussionmentioning

confidence: 99%

“…Data has the potential to be used by policy-makers and for audit, education and research purposes. Medication optimization using MedReview is possible even when face-to-face interactions are restricted [ 3 ].…”

Section: Discussionmentioning

confidence: 99%

“…Current medication review processes have certain limitations, including lack of a systematic and structured approach which leads to variations in the process; time and funding constraints; lack of integration at residential aged care facilities (RACFs) and lack of data storage to enable quality improvement; and the inability to conduct face-to-face reviews especially due to the coronavirus disease-19 (COVID-19) pandemic [ 3 ]. Medication review algorithms and minimization frameworks are used as guides in the medication review process, and aid reviewers in identifying medication-related problems thereby reducing harmful events among the older population [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Development, validation and evaluation of an online medication review tool (MedReview)

Thiruchelvam

Hasan²,

Pudmenzky³

et al. 2022

PLoS ONE

Self Cite

View full text Add to dashboard Cite

Objectives To develop, validate and evaluate a computerized clinical decision support system (MedReview) that aids medication reviewers with pharmacological decision-making. Methods This study included three phases; the development phase included computerizing a consolidated medication review algorithm (MedReview), followed by validation and evaluation of MedReview and responding to a web-based survey designed using patient scenarios. Participants had to be ‘fully registered’ with the Malaysian Pharmacy Board and work full-time at a community pharmacy. Results MedReview was developed as a web app. It was validated among 100 community pharmacists from May-July 2021 using the Technology Acceptance Model (TAM). There was acceptable content validity and fair inter-rater agreement, and good convergent and discriminant validity. Exploratory factor analysis resulted in five domains to determine the attitude of pharmacists about using MedReview: perceived ease of use, perceived usefulness, intention to use, trust, and personal initiatives and characteristics; the total variance explained by five factors was 76.36%. The survey questionnaire had a high overall reliability value of 0.96. Evaluation of MedReview was based on mean scores of survey items. Of all items included in the survey, the highest mean score (out of 7) was achieved for ‘I could use MedReview if it is meaningful/relevant to my daily tasks’ (5.78 ± 1.10), followed by ‘I could use MedReview if I feel confident that the data returned by MedReview is reliable’ (5.77 ± 1.21), and ‘I could use MedReview if it protects the privacy of its users’ (5.73 ± 1.20). Conclusion Community pharmacists generally had a positive attitude towards MedReview. They found that MedReview is trustworthy and they had the intention to use it when conducting medication reviews. The adaptation of the TAM in the survey instrument was reliable and internally valid.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%